B2B Software Technologies Appoints Dr. Avinash Yaramati as Non-Executive Director
B2B Software Technologies Limited (BSE: 531268) held its 31st Annual General Meeting on September 29, 2025, resulting in significant changes to its board and management structure. Dr. Avinash Yaramati, initially appointed as an Additional Director on July 12, 2025, was regularized as a Non-Executive Director. The AGM also approved the appointment of new Statutory Auditors, Secretarial Auditors, material related party transactions, and modifications to the terms of appointment for Mr. Bala Subramanyam Vanapalli, including performance bonus approval.

*this image is generated using AI for illustrative purposes only.
B2B Software Technologies Limited, a company listed on the Bombay Stock Exchange (BSE: 531268), has announced significant changes to its board and management structure following its 31st Annual General Meeting (AGM) held on September 29, 2025.
Key Developments
New Non-Executive Director
The company has regularized the appointment of Dr. Avinash Yaramati as a Non-Executive Director. Dr. Yaramati, who was initially appointed as an Additional Director on July 12, 2025, will now serve as a full-fledged board member, liable to retire by rotation.
Professional Background
Dr. Yaramati brings a wealth of medical expertise to the board. He holds an M.S. in General Surgery from Mamata Medical College and an M.B.B.S. from Mahatma Gandhi Medical College & Research Institute. His professional experience includes:
- Serving as Registrar in Surgical Gastroenterology at Star Hospitals, Hyderabad
- Academic roles at institutions such as NIMS, Sri Manakula Vinayagar Medical College, and Gayatri Medical College, Visakhapatnam
- Contributions to medical research through paper presentations at state-level conferences and publications in peer-reviewed scientific journals
Other AGM Resolutions
The 31st AGM, conducted via video conferencing, saw the approval of several other important resolutions:
- Appointment of M/s. M. V. Vijaya Kumar & Co. (Firm Registration No. 007890S) as the new Statutory Auditors of the company
- Approval of material related party transactions with Antelope Valley Cancer Center, USA, in collaboration with Genius doc
- Appointment of M/s DSMR & Associates as the company's Secretarial Auditor for a term of five consecutive financial years (2025-26 to 2029-30)
- Modifications to the terms of appointment for Mr. Bala Subramanyam Vanapalli, including perquisites and ESOP grants
- Approval of performance bonus for Mr. Bala Subramanyam Vanapalli for the Financial Year 2024-2025
Corporate Governance
B2B Software Technologies has demonstrated its commitment to corporate governance by ensuring timely disclosures and seeking shareholder approval for key decisions. The appointment of new auditors and the regularization of Dr. Yaramati's position on the board reflect the company's efforts to strengthen its leadership and compliance framework.
B2B Software Technologies Limited continues to evolve its board composition and corporate structure, potentially positioning itself for future growth and diversification in the technology sector.
Historical Stock Returns for B2B Software Technologies
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-2.16% | -2.04% | -4.46% | +16.04% | -18.91% | +189.71% |